AGTR1 and pulmonary fibrosis: With respect to AT1 and lung fibrosis, four studies [2,7-9] of an animal model of bleomycin (BLM)-induced pulmonary fibrosis revealed that treatment with an AT1A suppressed pulmonary hydroxyproline levels, and, therefore, AT1As can suppress pulmonary fibrosis.